Literature DB >> 11994020

CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Matthias Maschke1, Oliver Kastrup, Hans-Christoph Diener.   

Abstract

Cytomegalovirus (CMV) infection of the CNS occurs most commonly in patients with severe immunosuppression such as those with advanced HIV infection (i.e. AIDS) or those who have undergone bone marrow or solid organ transplantation. Immunocompetent patients are affected very rarely. The infection of the CNS may affect the brain (diffuse encephalitis, ventriculoencephalitis, cerebral mass lesions) or the spinal cord (transverse myelitis, polyradiculomyelitis). Diagnosis is very difficult and should be based on clinical presentation, results of imaging and virological markers. The most specific diagnostic tool is the detection of CMV DNA by polymerase chain reaction in the CSF. Treatment should be initiated promptly if CMV infection is suspected. Antiviral therapy consists of intravenous ganciclovir, intravenous foscarnet or a combination of both. Cidofovir is the treatment of second choice. Patients who experience clinical improvement or stabilisation during induction therapy should be given maintenance therapy. After immune reconstitution (in HIV-positive patients) or discontinuation of immunosuppressive therapy (in transplant recipients), maintenance therapy may be stopped. Despite therapy, the prognosis for long-term survival is very poor, especially in patients with AIDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994020     DOI: 10.2165/00023210-200216050-00003

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  86 in total

1.  The utility of clinical and radiographic features in the diagnosis of cytomegalovirus central nervous system disease in AIDS patients.

Authors:  D G Burke; D G Leonard; T F Imperiale; H Valdez; B Karaman; E Shick; R C Kalayjian
Journal:  Mol Diagn       Date:  1999-03

Review 2.  Progress in understanding cytomegalovirus drug resistance.

Authors:  V C Emery
Journal:  J Clin Virol       Date:  2001-06       Impact factor: 3.168

3.  Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS.

Authors:  R Enting; J de Gans; P Reiss; C Jansen; P Portegies
Journal:  Lancet       Date:  1992-08-29       Impact factor: 79.321

Review 4.  Opportunistic infections of the central nervous system during HIV-1 infection (emphasis on cytomegalovirus disease).

Authors:  E Roullet
Journal:  J Neurol       Date:  1999-04       Impact factor: 4.849

5.  Human pharmacokinetics of the antiviral drug DHPG.

Authors:  C Fletcher; R Sawchuk; B Chinnock; P de Miranda; H H Balfour
Journal:  Clin Pharmacol Ther       Date:  1986-09       Impact factor: 6.875

6.  Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis.

Authors:  D B Clifford; J R Arribas; G A Storch; W Tourtellote; F J Wippold
Journal:  J Neurovirol       Date:  1996-12       Impact factor: 2.643

Review 7.  Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C Sindic; G Gerna; A M van Loon; P E Klapper
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

8.  Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis.

Authors:  U R Hengge; N H Brockmeyer; R Malessa; U Ravens; M Goos
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

9.  MRI of AIDS-related polyradiculomyelitis.

Authors:  M L Whiteman; B K Dandapani; R T Shebert; M J Post
Journal:  J Comput Assist Tomogr       Date:  1994 Jan-Feb       Impact factor: 1.826

10.  Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system.

Authors:  J R Arribas; D B Clifford; C J Fichtenbaum; D L Commins; W G Powderly; G A Storch
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  22 in total

1.  Cytomegalovirus Encephalitis in a Patient with Severe Combined Immunodeficiency.

Authors:  Mitsuo Motobayashi; Tomonari Shigemura; Miyuki Tanaka; Takashi Kurata; Norimoto Kobayashi; Kazunaga Agematsu; Yoshiro Amano; Yuji Inaba; Kenichi Koike; Yozo Nakazawa
Journal:  J Clin Immunol       Date:  2015-11-07       Impact factor: 8.317

2.  Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults.

Authors:  Craig B Wilen; Cynthia L Monaco; Joan Hoppe-Bauer; Ronald Jackups; Robert C Bucelli; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

3.  Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Authors:  N Goerig; S Semrau; B Frey; K Korn; B Fleckenstein; K Überla; A Dörfler; F Putz; U S Gaipl; R Fietkau
Journal:  Strahlenther Onkol       Date:  2016-05-31       Impact factor: 3.621

4.  A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantations.

Authors:  Toshihiro Matsukawa; Hideki Goto; Kenta Takahashi; Shinsuke Asanuma; Atsushi Yasumoto; Mutsumi Takahata; Akio Shigematsu; Tomoyuki Endo; Junji Tanaka; Satoshi Hashino; Shinya Tanaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2012-01-20       Impact factor: 2.490

5.  Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.

Authors:  Nicole L Goerig; Benjamin Frey; Klaus Korn; Bernhard Fleckenstein; Klaus Überla; Manuel A Schmidt; Arnd Dörfler; Tobias Engelhorn; Ilker Eyüpoglu; Paul F Rühle; Florian Putz; Sabine Semrau; Udo S Gaipl; Rainer Fietkau
Journal:  Neuro Oncol       Date:  2016-06-10       Impact factor: 12.300

6.  Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.

Authors:  Nahid Akhyani; Julie Fotheringham; Karen Yao; Farzin Rashti; Steven Jacobson
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

Review 7.  Neuroimaging of herpesvirus infections in children.

Authors:  Henry J Baskin; Gary Hedlund
Journal:  Pediatr Radiol       Date:  2007-05-22

8.  Unravelling the Gordian knot: diagnostic dilemma in an HIV-positive patient with neurological involvement.

Authors:  Avirup Chakraborty; Sattik Siddhanta; Kuntal Bhattacharyya; Amit Das; Siwalik Banerjee; Rathindra Nath Sarkar; Utpal Kumar Datta; Nilanjan Chakraborty
Journal:  BMJ Case Rep       Date:  2013-04-23

Review 9.  Opportunistic infections of the CNS in patients with AIDS: diagnosis and management.

Authors:  Julio Collazos
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Cytomegalovirus encephalitis in an immunocompetent pregnant woman.

Authors:  W R Saliba; R Raz; Y Keness; L H Goldstein; A Reshef; M Elias
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-25       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.